| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |